Despite continuing medical advances, the worldwide burden of illnesses continues to expand every year. In a study, the Institute for Health Metrics and Evaluation (IHME) emphasized that a total of 359 fresh illnesses and accidents were added to the fatal and non-fatal list of circumstances between 1950 and 2017. Some of the most prevalent instances include cancer, heart disease, stroke, breathing infections, lung disease, Alzheimer’s, diabetes, and kidney disease. While some of these circumstances are unpreventable, creative therapy and medicine can solve circumstances such as cancer and heart problems or slow their spread. For example, cancer patients typically receive therapies such as chemotherapy or radiotherapy. Chemotherapy and radiotherapy are two of the most prevalent cancer treatments directed at prolonging the life expectancy of malignant cells, controlling them or eliminating them. And despite its efficacy, biotechnology firms continue to create unique and innovative treatments such as focused therapies or personalized treatments. However, while biotechnology firms are advancing within the sector, more and more instances of medical circumstances are emerging around the globe every year.
Most cancer patients are usually treated similarly depending on their specific type of cancer as well as the progression of the stage. Researchers, though, began to realize that treatments were more beneficial for some people, while others received little to no response. As such, scientists realized that genetic variations can affect how they react to the therapy in each patient. For example, a patient who can process medicine much more quickly than others would probably need a greater dose of medicine to be efficient. Besides, serious side effects from particular cancer drugs are experienced by some patients, making the method untenable. And in some cases, to reduce the painful side effects, doctors will either prescribe additional medicine or lower the dosage.